Avid Bioservices (CDMO) Misses Q2 EPS by 17c

Avid Bioservices (NASDAQ: CDMO) reported Q2 EPS of ($0.27), $0.17 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $33.5 million versus the consensus estimate of $33.8 million.

For earnings history and earnings-related data on Avid Bioservices (CDMO) click here.

You May Also Be Interested In

• Gulfport Energy and Mobility Global to join S&P SmallCap 600
• Tractor Supply and Starlink team up to expand rural broadband via 4-H
• Deutsche Bank Downgrades Synaptics (SYNA) to Hold